Additionally, another pan-cancer scoring scheme, namely, immunophenoscore, was built using machine learning to identify determinants of tumor immunogenicity for response to anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) and anti-PD-1 therapy (77). The gene discussed is CTLA4; the disease is neoplasm.